Drug Trial Radar · NCT07589634
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
230
Planned (sponsor's estimate)
Start
Jun 30, 2026
Primary completion
Dec 31, 2027
Study completion Jul 30, 2030
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- May 15, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to find out whether giving a single dose of tocilizumab before treatment with ramantamig can help prevent or reduce the severity of cytokine release syndrome (CRS) within 28 days from ramantamig, compared to participants who receive placebo. CRS is an acute inflammatory reaction that can occur during treatment and may be associated with flu-like or other systemic symptoms, such as fever and tiredness.
Conditions
- Multiple Myeloma
Interventions
RamantamigDrug
Ramantamig will be administered as subcutaneous (SC) injection.
TocilizumabDrug
Tocilizumab will be administered as intravenous (IV) injection.
PlaceboDrug
Placebo (saline) will be administered as IV injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Alive and Free of Treatment-Emergent American Society for Transplantation and Cellular Therapy (ASTCT) Grade Greater Than or Equal to (>=) 2 Cytokine Release Syndrome (CRS)Time frame: By the end of Day 28 from first ramantamig dose
Locations
60 sites in 10 countries. Site status is shown where the registry gives one.
City of Hope Phoenix
Goodyear, Arizona · Recruiting
Beverly Hills Cancer Center (BHCC)
Beverly Hills, California · Recruiting
City of Hope Orange County Lennar Foundation Cancer Center
Irvine, California · Recruiting
Stanford University Medical Center
Palo Alto, California · Recruiting
Colorado Blood Cancer Institute
Denver, Colorado · Recruiting
Washington University School Of Medicine
St Louis, Missouri · Recruiting
Ohio Health Research Institute
Columbus, Ohio · Recruiting
Sarah Cannon Research Institute
Nashville, Tennessee · Recruiting
University of Utah Huntsman Cancer Institute
Salt Lake City, Utah · Recruiting
Hospital Aleman
Buenos Aires, Argentina · Recruiting
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina · Recruiting
Instituto Alexander Fleming
Buenos Aires, Argentina · Recruiting
Hospital Privado Centro Medico de Cordoba
Córdoba, Argentina · Recruiting
Hospital Universitario Austral
Pilar, Argentina · Recruiting
Flinders Medical Centre
Bedford Park, Australia · Recruiting
Sunshine Coast University Hospital
Birtinya, Australia · Recruiting
Concord Repatriation General Hospital
Concord, Australia · Recruiting
St Vincents Hospital Melbourne
Fitzroy, Australia · Recruiting
Wollongong Hospital
Wollongong, Australia · Recruiting
Centre Hospitalier Victor Dupouy
Argenteuil, France · Recruiting
Centre Hospitalier de la Cote Basque
Bayonne, France · Recruiting
CHU de Grenoble
La Tronche, France · Recruiting
Centre de Cancerologie de la Sarthe
Le Mans, France · Recruiting
CHU Nantes - Hotel Dieu
Nantes, France · Recruiting
Centre Hospitalier de Quimper Cornouaille
Quimper, France · Recruiting
Uni General Hospital of Alexandroupolis
Alexandroupoli, Greece · Recruiting
251 Air Force General Hospital
Athens, Greece · Recruiting
Alexandra General Hospital of Athens
Athens, Greece · Recruiting
Metaxa Cancer Center Hospital Of Piraeus
Piraeus, Greece · Recruiting
General University Hospital of Patras
Rio, Greece · Recruiting
Theageneio Cancer Hospital
Thessaloniki, Greece · Recruiting
Hippokration Hospital
Thessaloniki, Greece · Recruiting
Semmelweis Egyetem
Budapest, Hungary · Recruiting
Del Pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet Szent Laszlo Telephely
Budapest, Hungary · Recruiting
Orszagos Onkologiai Intezet
Budapest, Hungary · Recruiting
Pecsi Tudomanyegyetem Klinikai Kozpont
Pécs, Hungary · Recruiting
Szegedi Tudomanyegyetem Altalanos Orvostudomanyi Kar
Szeged, Hungary · Recruiting
Hospital Ampang
Ampang, Malaysia · Recruiting
Hospital Pulau Pinang
George Town, Malaysia · Recruiting
Hospital Sultanah Aminah
Johor Bharu, Malaysia · Recruiting
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.